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Clinician views of patient decisional conflict when deciding between dialysis or 1 
conservative management: qualitative findings from the PAlliative Care in chronic 2 
Kidney diSease’ (PACKS) study. 3 
 4 
Short title: Clinician views of patient decisional conflict when deciding between dialysis 5 
or conservative management. 6 
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 9 
Abstract 10 
Background Only a paucity of studies have addressed clinician perspectives on patient 11 
decisional conflict, in making complex decisions between dialysis and conservative 12 
management (renal supportive and palliative care).   13 
Aim To explore clinician views on decisional conflict in patients with end-stage kidney 14 
disease 15 
Design Interpretive, qualitative study 16 
Setting and Participants As part of the wider National Institute for Health Research, 17 
PAlliative Care in chronic Kidney diSease’ (PACKS) study, semi-structured interviews 18 
were conducted with clinicians (nephrologists n=12; 7 female and clinical nurse specialists 19 
n=15; 15 female) across 10 renal centres in the UK. Interviews took place between April 20 
2015 and October 2016 and a thematic analysis of the interview data was undertaken. 21 
Results Three major themes with associated subthemes were identified. The first, “Frequent 22 
changing of mind regarding treatment options,” revealed how patients frequently altered their 23 
treatment decisions, some refusing to make a decision until deterioration occurred. The 24 
second theme, “Obligatory beneficence” included clinicians helping patients to make 25 
informed decisions where outcomes were uncertain. In weighing up risks and benefits, and 26 
the impact on patients, clinicians sometimes withheld information they thought might cause 27 
concern. Finally, ‘Intricacy of the decision’ uncovered clinicians’ views on the momentous 28 
and brave decision to be made. They also acknowledged the risks associated with this 29 
complex decision in giving prognostic information which might be inaccurate.   30 
Limitations Relies on interpretative description which uncovers constructed truths and does 31 
not include interviews with patients.  32 
Conclusions Findings identify decisional conflict in patient decision-making and a tension 33 
between the prerequisite for shared decision-making and current clinical practice. Clinicians 34 
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also face conflict when discussing treatment options due to uncertainty in equipoise between 35 
treatments and how much information should be shared. The findings are likely to resonate 36 
across countries outside the UK.  37 
(287 words) 38 
 39 
What is already known about the topic? People diagnosed with end-stage kidney disease 40 
(ESKD) face a difficult decision-making process and choices regarding renal replacement 41 
therapy are perplexing, multifaceted and preparation for treatment often suboptimal. Frail 42 
patients with multiple co-morbid conditions may find it challenging to determine the benefits 43 
of renal replacement therapy and how it might fit into their existing lifestyle. Some may opt 44 
for Conservative Management (CM), a palliative care approach aimed at improving quality of 45 
life until death, without dialysis. Clinicians’ views on decisional conflict in patients deciding 46 
between dialysis and CM are largely unknown. 47 
  48 
What this paper adds? Patients are unlikely to fully appreciate the severity of their 49 
condition if clinicians act to prevent discussion of declining health and approach of death. 50 
This study uncovers a conflicted decision-making process along with confusion surrounding 51 
the benefits, risks and side-effects of treatments in end-stage kidney disease. Patients 52 
frequently change their mind over treatment options. Clinicians counsel patients to assist 53 
them make the decision that clinicians think would be in their best interests. There continues 54 
to be a reluctance to focus on the negative aspects of treatment, such as difficult symptoms 55 
and limited prognosis. 56 
 57 
Implications for practice, theory or policy? 58 
There is a distinct lack of knowledge about how practitioners assist patients in their decision-59 
making, particularly those for whom dialysis may proffer little benefit. There is an ongoing 60 
need to provide education and training on this topic. Decision aids which encourage people to 61 
be more actively involved in decision-making and improve risk perceptions and congruence 62 
between the choice made and patient values might be a helpful addition to renal clinical 63 
practice.  64 
 65 
 66 
 67 
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Background 68 
Renal replacement therapy (RRT) has steadily increased due to population ageing and 69 
epidemiological factors such as the growing prevalence of diabetes and concomitant vascular 70 
deficits1. Global incidence rates for RRT range from 12 to 455 (median 130) per million 71 
population2. The international population who opt not to dialyse has not been assessed3 72 
although this recourse is recognised as a treatment option in many countries4.People 73 
diagnosed with end-stage kidney disease (ESKD) face a particularly difficult decision-74 
making process5 6. Choices regarding renal replacement therapy are perplexing and 75 
multifaceted7. Frailer patients with additional co-morbid conditions may not envisage any 76 
clear benefits of renal replacement therapy8,9. Impaired cognition may have further negative 77 
impact on  decision-making processes10.Some patients may opt for Conservative 78 
Management (CM) aimed at improving quality of life until death, without dialysis, supported 79 
by an interdisciplinary team11. To reach an optimum treatment decision with a patient 80 
deciding between dialysis and CM, a shared decision-making approach involving members of 81 
the healthcare team is advocated 12,13,14,15,16. “Patient-centred care” focuses on patients and 82 
their carers rather than their diseases11 and is synonymous with care responsive to the needs 83 
and values of patients17,18,19. Sharing of information should include treatment options, risks 84 
and benefits of treatments and an informed exploration of preferences and values 8,16,20, 21 .  85 
Renal clinicians tend to focus on biomedical factors and have an inherent instinct to prolong 86 
life22. Nephrologists often struggle to explain the complexity of illness, tending to avoid 87 
discussions of the future23 24 in order to maintain hope25.  Morton and colleague’s systematic 88 
review26 on decision-making regarding treatment for chronic kidney disease reported a lack 89 
of choice in the medical decision, a deficiency of information and resource constraints, with 90 
needs of patients and families not being met. Poor timing of information about all possible 91 
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treatment options may result in haemodialysis being the most frequent choice for patients 92 
with end-stage kidney disease22. 93 
Decisional conflict is a measure of uncertainty concerned with treatment choices and 94 
patients’ confidence in making decisions27. It is likely to arise when there is outcome 95 
uncertainty5 and may impact on the quality of the decision28. Decisional regret is a term 96 
describing a sense of self-blame for a decision which failed to produce a desired outcome29. 97 
Decisional conflict usually accompanies decisional regret and may contribute to patients 98 
apportioning blame to clinicians for a poor decision28. Clinicians have a fundamental role to 99 
play in helping patients make patient-centred decisions and may be assisted by decision-aids 100 
which have been shown to improve decision-making 27, 30. If patients make informed 101 
decisions, decisional conflict is likely to be reduced. The difficulties inherent in the decision-102 
making process related to choices between dialysis or CM, arise from the limited evidence on 103 
which types of patients might fare best 31and limited guidance on best practice 21, 32 The 104 
National Institute for Health Services ‘PAlliative Care in chronic Kidney disease’ (PACKS) 105 
study33, is exploring quality of life, frailty, performance, cognition and decisional conflict in 106 
patients who decide not to embark on dialysis34. It is also investigating the economic costs of 107 
providing palliative care services, and the impact on carers, and is open across 10 renal 108 
centres in the UK. It will complete in May 2017. This paper reports the qualitative 109 
component of the PACKS study which aimed to explore decisional conflict in patients from 110 
the clinicians’ perspective and the use of decision aids in clinical practice. 111 
 112 
Methods 113 
Design and Setting 114 
Interpretive description, a qualitative methodology, was employed to inform understanding of 115 
decisional conflict in patients with kidney disease making treatment decisions from the 116 
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perspective of clinicians35 36. Semi-structured interviews were completed with nephrologists 117 
and clinical nurse specialists recruited from 10 of the 70 main renal units in the UK (five in 118 
Northern Ireland, four in England and one in Scotland). Each unit offers patients renal 119 
replacement therapy or CM. We used interpretative description of interviews with clinicians, 120 
to generate knowledge related to the clinical context. The ontological and epistemological 121 
traditions of human science research, guide interpretive description 37, blending hermeneutic 122 
practices and the empirical methods of qualitative methodology. This methodology rejects the 123 
view of a single, absolute reality, assuming existence of multiple realities, related to context, 124 
and subjectively constructed through social interaction36. It aims to interpret the world of the 125 
participants, exploring lived experiences in everyday situations in practice and is concerned 126 
with human experience.  Interpretive description acknowledges the co-construction that 127 
occurs through shared understandings of the researcher and the participants and identified 128 
through constant comparative methods 38 39 40 . The findings can produce new theory and 129 
inform clinical thinking, inventive care practices, and the development of policy.   130 
Questions for the interview were based on and extracted from the Decisional Conflict Scale 131 
(DCS) 41, a 16-item scale used to assess patient uncertainty about medical decisions. The 132 
DCS uses structured questions to elicit responses related to decisional conflict. In the present 133 
study the DCS questions were adapted and employed within a semi-structured interview to 134 
elicit rich, detailed responses related to decisional conflict, its identification and management. 135 
For example, one question on the DCS asks: ‘Did you know the benefits of each option’ and 136 
requires a Likert scale response between ‘strongly agree’ and ‘strongly disagree’. This was 137 
altered to an open ended question, ‘Do you think patients know the benefits of each option 138 
offered to them and why’? (Table 1). One additional question was asked – ‘What 139 
guidelines/decision tools do you use with your patients when helping them make treatment 140 
decisions?’  141 
6 
 
Participants 142 
A purposive sampling technique42 was used to identify nephrologists and renal clinical nurse 143 
specialists at the units participating in the PACKS study, who met the inclusion criteria, 144 
which included being employed in the renal specialty and with experience of managing 145 
clinical consultations of patients with stage 5 chronic kidney disease who opt for CM. This 146 
permitted a variety of experiences across renal units. Purposive sampling enabled the 147 
researcher to choose individuals whose experiences helped achieve the aims of the study and 148 
who could provide information-rich experiences43. Potential participants were identified with 149 
the ten Principal Investigators at each site, and approached by email or in person, by the 150 
Chief Investigator.  151 
Interviews 152 
Once written informed consent was received, participants were interviewed face-to-face in an 153 
outpatient office (n=20) or over the telephone (n=7) by the Chief Investigator, an experienced 154 
qualitative researcher.  Interviews were completed between April 2015 and October 2016.  155 
The interviewer presented herself as an unbiased nonclinical observer, with previous 156 
experience in nephrology nursing, interested in understanding the views of the participants. 157 
She was known to some in her role as Chief Investigator in the PACKS study.  158 
Interviews were audio recorded and transcribed verbatim. Transcripts were read and re-read 159 
by the interviewer and one other member of the research team (SH). Coding was undertaken 160 
and passages of text identified that discussed topics similarly. Coding allowed for 161 
comparisons and identification of patterns in the data44. All other team members read a 162 
selection of transcribed interviews in order to compare insights and developing themes. The 163 
transcripts were not returned to participants. Interviews continued until data saturation, and 164 
no new codes were identified 45. Field notes were recorded after interviews and these 165 
informed data interpretation.  166 
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Data Analysis 167 
A thematic approach to analysis44, which followed a process of examining emergent patterns 168 
or themes, was applied to the data. It commenced with initial data analysis by the Chief 169 
Investigator using Microsoft Word to facilitate coding46. Guidance by Hahn47 was followed 170 
and features of Word were used to organize the analysis of data and as a means of facilitating 171 
efficient qualitative coding. Initial coding was undertaken and codes subsequently reduced 172 
and summarised based on meaning. Finally data were refined into overarching themes 173 
supported with rich quotes from participants. Analysis, discussion and checking of findings 174 
occurred with a second member of the research team (SH), and a random selection of 175 
interviews were shared with the wider team to share insights and initial findings.  176 
Participant characteristics 177 
37 clinicians were invited to participate in the study. Nine did not respond and one refused 178 
due to workload.  27 clinicians participated in interviews and included nephrologists (n=12; 7 179 
female) and clinical nurse specialists (n=15; 15 female). The average years of renal 180 
healthcare experience was 18 (range 10-33). Participants ranged in age from 30-39 years 181 
(n=6), 40-49 (n=14), 50-59 (n=7). Three participants were Asian, two Afro-Caribbean, two 182 
Chinese and 20 white (see Table 2). Interviews lasted between 19 and 35 minutes.  183 
 184 
Findings 185 
THEME 1: Frequent changing of mind regarding treatment options 186 
Clinicians described how patients regularly changed their minds about treatment options 187 
‘toing and froing’ as treatment decisions were ruminated. The clinical condition and natural 188 
history of each patient’s illness often impacted on this indecision and increased symptom 189 
burden usually precluded a change of mind.  190 
So there is so much time for changing of minds and for one week, feeling okay, and then maybe a bit of a urinary 
infection and feeling so unwell, and then back to normal …then decisions can change and they’ll say I do want it, or 
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I don’t want any treatment, and then they say I do want treatment, and then they come back and say I don’t want it, 
and change their mind again (CNS09). 
*CNS=Clinical Nurse Specialist 
         191 
Clinicians laughed demonstrating humour, whilst expressing exasperation and occasional 192 
sadness at these constant changes. They appreciated difficulties presented to patients when 193 
attempting to make an informed decision regarding treatments of which they had no prior 194 
experience. 195 
Ha-ha [laughing], I’m trying to think percentage-wise, but we get patients that choose hospital dialysis as their first 
option, and then it would be peritoneal dialysis, and then it would be conservative treatment, but I have seen some 
medical clinicians encourage those patients to change their mind, and some have changed their mind, and I have 
seen patients go on, start dialysis, hate it, and withdraw from dialysis, even though their original plan was never to 
start this, and I think, well, it is sad (CNS18).   
 
And then, when the time comes, you’re saying, “You’ve made that decision”, “No, I think I will have dialysis now,” 
you know [laughing], they will change their mind (CNS08). 
Three subthemes help elucidate the reason for frequent changes in decision-making. 196 
Denial and fear 197 
All clinicians, bar one, felt the decision whether or not to embark on dialysis was bewildering 198 
for patients. They described patients in denial, often fearful of the decision, anxious that they 199 
were taking a ‘proactive decision towards death’. Cognitive dysfunction, language barriers 200 
and uraemia were reported as contributing towards perplexity. Additionally and conversely, 201 
patients often delayed decision-making whilst feeling reasonably well and some avoided 202 
meeting with healthcare practitioners in order to avoid a decision. 203 
They might be in denial.  Their educational level might not be that good.  Also, there could be a language barrier.  
They could be uremic if we get referrals at a late stage. Their cognitive function might not be as great as we 
expect.  So, for all those reasons, I don’t think it is 100% (CNS04). 
It’s people who are brought back continually to clinic, and keep coming back, because they’re well, …they will 
not decide until nearer the time if they really do want dialysis, and if in their hearts they don’t know they might 
stop coming – they will cancel their appointments  (CNS10). 
This caused consternation amongst clinicians observing the turmoil of patients confronting 204 
deterioration and progress of a disease that would ultimately lead to their death. Clinicians 205 
aspired to encouraging patients to accept their diagnosis and treatments but attempted to 206 
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soften the impact of diagnosis and reduce fear; taking an optimistic stance and offering 207 
encouragement throughout the patient denial process.   208 
So they focus more on the bad side and what will happen to them because they think that once they have kidney 
failure, they die. There is no hope.  So it depends on the staff, how you educate them, how you kind of give them 
the information that will give them inspiration. Look, you’re not the only one But it’s so hard because they’re 
already in denial and you’re trying to give them a positive side. You can have this option.  It’s the same as 
supportive care.  You’re not telling them that you’re dying.  You also tell them about other patients. “We have this 
patient, but they are doing well,” so you kind of in a way encourage them as well, don’t tell them all the side effects, 
and you tell them “You are fit person – it could be good to you - you don’t scare them (CNS05) 
 209 
Influences from families and other patients 210 
Families and other patients impacted upon and helped inform the decision-making process. 211 
Families who displayed difficulties accepting a loved one’s diagnosis of kidney disease might 212 
encourage patients to accept a treatment they had previously declined. Patients, reluctant to 213 
cause family upset, might be persuaded to change their decision in such a setting, especially 214 
if they were experiencing difficulty with acceptance of clinical status themselves.  215 
I think a lot of elderly people are forced into dialysis when they would otherwise not have preferred to have 
dialysis.  Their families are keen for them to live longer and so they’re pressured into getting dialysis (N13). 
 
I think the bigger problem is that patients’ relatives, who, no matter what you tell them about dialysis, feel that 
their mother or father should be on treatment, and I think that’s a much more difficult thing for the patient to 
ignore because they’re with their family member, you know, most of the time, and if it’s causing the family 
member upset, they’re probably just going to go ahead with the dialysis. So that is a big issue that we have 
(N16). 
 
Sometimes they start to hear things or see things from other patients, if they’re around the hospital and talk to 
other people (CNS06). 
 
When patients deteriorated and couldn’t participate in the decision making process, some 216 
family members took responsibility, assuming that a lack of capacity had supervened; this 217 
occasionally resulted in them overturning the patients’ previously indicated preference.  218 
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Unfortunately, he was beginning to get uremic and beginning to lose capacity and it all completely unraveled. I feel 
at that point that the family had made a decision for that patient, that the patient hadn’t necessarily made 
themselves but the patient had lost capacity at this stage to make his own decision (N09) 
Some family members demanded they be heard and listened to, opting to take responsibility 219 
for the decision. In some instances the patient appeared unable to voice an opinion.  220 
Some families just demand “I want my dad to dialyse,”, they don’t give their relative a chance to decide…It’s very 
hard because the family can be very, very strong…. “No, I decide, you know – I am the head of the family and I 
decide (CNS04).”   
 
The family, usually Asians, they’re very strong and say “No, we want our mum to dialyse.”   So, even if we decided 
in the clinic already that they won’t dialyse, they will say to another doctor that “Oh no, we want our mum to 
dialyse,” and that doctor often says “Yeah, we will dialyse your mum (N06).” 
 221 
Clinician encouragement to change mind 222 
Although patients frequently changed their treatment decisions, clinicians reported 223 
encouraging this phenomenon, recognizing and appreciating the complexity inherent in such 224 
decisions. They felt it was almost impossible for patients to make an informed decision about 225 
treatments which they hadn’t personally experienced. 226 
I’m quite content and comfortable if they want to change their mind either to go towards dialysis or to come 
away from dialysis, and I would deal with them as and when.  I don’t think anybody chops and changes every 
five minutes, but it’s a big decision and I think people have got to have the right to be able to change their mind 
(N15). 
 
It’s really only when you’re in it that you’re truly informed [laughing], no matter how much education you’ve had 
about something (N13).   
Although they realised that fluctuating between decisions meant some patients wouldn’t be 227 
prepared appropriately for treatment, clinicians accepted that patients needed to be allowed to 228 
change their minds right up until treatment commenced. That said, if the decision could be 229 
finalised in good time, clinicians felt patients would be more prepared for treatment: 230 
 231 
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You really hope in your heart though that they don’t change their mind because, obviously, you know, getting a line 
in, last minute, unplanned, isn’t good but you do tell them they can change their mind  (CNS21). 
THEME 2: Obligatory beneficence 232 
In the patient’s best interests  233 
Although clinicians felt they had to help patients make the best choices, they didn’t wish to 234 
cause harm. Their role was to advise patients on treatment options, weighing up what 235 
information required sharing to inform patient decisions.  Some clinicians believed that they 236 
had a good knowledge of their patients’ values having, in some cases, treated them for many 237 
years. They felt able to act in an advocacy role on behalf of the patient although some 238 
clinicians were less comfortable with this approach. Views varied on what constituted open 239 
and informed patient- centred decision making. It was thought that enabling a patient’s 240 
autonomous decision could potentially conflict with the beneficent or non-maleficent role of 241 
clinicians to ensure what was in the patient’s best interests. 242 
We say it’s always about patient choice, but there’s no doubt that there’s a large medical steer in that.  You 
know, if you show someone all the options, a lot of the time, they say, you know,” What do you think?” and 
obviously, you can guide people down a path because you think it’s the right thing for them (N11). 
 
I feel our patients are aware of some treatment options, but maybe not all treatment options. There is a slight 
bias with the doctors probably in giving treatment options out because we sometimes make assumptions that 
some treatment options may not be suitable (N16) 
 
So I think, as a Renal Team, we do have to be very careful that we don’t go in with our fixed ideas, and we do 
have to listen to the individual because they are an individual, and that has challenged us (CNS20).   
In order to help patients with their decision it was felt an individualised, bespoke approach to 243 
care was indicated. This precluded the use of decision aids or guidelines, which were 244 
generally viewed negatively and unhelpful within such a multifaceted and multifarious 245 
decision-making process. Laughter and humour were again apparent within such narratives. 246 
 247 
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Not really, no.  We don’t have decision tools.  We just give the information to them and then ask them to make the 
decision (CNS01) 
 
There is one we use…I’ve forgotten the name of it. I use it on the computer. I’ve completely forgotten the name.  I 
haven’t used it in a while (CNS03). 
 
Consultant: With treatment decisions [Decision Aids]? No. 
Interviewer: That’s alright.  Why are you laughing? 
Consultant: Because we’ve talked about it, you’ve got all these various sites, mainly generated from England, – UK 
Kidney Care, the English sites, and I think when you have a frail patient, who’s got multiple comorbidities, it’s quite 
difficult to get them to go through all of that [laughing]… (N14) 
Some clinicians felt that their clinical judgment was sufficient and that it was relatively easy 248 
to identify the most suitable choice of treatment.  249 
No.  I just usually use my own clinical knowledge, depending on their comorbidities. Sometimes it’s clearly obvious 
what’s best for them and you don’t need a decision aid by any stretch of the imagination [laughing].  Sometimes, 
the nurses will be part of the decision aid …But no, we don’t have any formal policies, as it were.  The only time I 
could quote any sort of numbers or anything at them is in supportive care if they’re asking me about life 
expectancy.  Then I might talk to them a bit about certain evidence that they’ll do less well on dialysis than 
supportive care, but we don’t have any formal algorithms, no.  It’s all sort of on an individual basis really (N06) 
 250 
Influencing the decision 251 
Some clinicians acted to induce a patient to make a particular decision if they felt they were 252 
not choosing an appropriate treatment. This was again undertaken within an advocacy role, 253 
with the best interests of the patient paramount.  254 
I have had patients who have refused to engage in dialysis planning, and they’re clearly not wanting conservative 
management.  And I have been very naughty and said “Look, if we don’t move forward with this dialysis planning, 
the alternative is you don’t get dialysis and I’m sending you to somebody to talk about what it means not to have 
dialysis,” and I’ve done that, and then they come back and they say, “Right, okay, I’ll have dialysis now…  You may 
say that’s very naughty, but it’s helpful for the patient (CNS10). 
 
We keep telling them you need to be realistic, you’re still well, you’re working, you’re very active, so, I think the 
best thing would be to embark on active treatment, but, some patients will just say… “No, I don’t really want it. But 
we keep on, telling them that you really need it at the moment “No, we really need to be realistic – you need to make 
a realistic decision regarding your care.”  A patient recently said, “I’m doing this for you,” and I said, “No, it’s not 
for me, it’s for your own good (CNS01). 
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I mean, we don’t coerce them into it, but we do guide …because you know yourself which is the best modality for a 
patient, so we would guide, but… they have the support of their families as well.  So there’s a lot of guidance from 
all directions (N14) 
 255 
When asked how informed patients were about the risks and side-effects of treatment, some 256 
clinicians described deliberate withholding of unpleasant information. Sometimes it was felt 257 
that too much detail about dialysis side effects could lead to a refusal to accept dialysis. This 258 
was particularly applicable to older, frailer patients’ although some clinicians were unhappy 259 
with this approach. Clinicians justified withholding information believing that patients might 260 
not want prognostic detail. They felt that providing a negative viewpoint might coerce 261 
patients to think about concerns they had never considered.   262 
You know, an elderly, frail patient, you’re not going to overload them with a lot of scary complications and side-
effects because you might potentially upset them…  So, again, there’s a wee bit of bias in patient selection as to 
how much negative information you want to give a patient (N16). 
 
I think we could do better in trying to make people realise that a major organ within their body is failing, and that 
they have to face that reality.  So, I don’t think we really [sighing]…  We could do better addressing end of life 
issues and looking at the impact of prognosis on all of that. I suppose we find that hard within Renal because it’s 
so difficult (CNS20) 
 
I don’t tell them explicitly about life expectancy … The reason I don’t do that is because I think at that stage in life, 
patients still don’t feel that renal disease, nor do I think they ever will think that renal disease is like a terminal 
illness, and I think it’s wrong to introduce that concept “Oh, by the way, do you know you’ve got the life expectancy 
of a patient with lung cancer?” and you’re 80 and about to go onto haemodialysis (N09). 
 
If they haven’t asked me, I may be telling them something they don’t want to know, and even by asking them, “Do 
you know what your life expectancy is?” that’s suddenly putting an idea into their head which wasn’t there 
(CNS23). 
THEME 3: The intricacy of the decision 263 
A momentous decision  264 
Clinicians articulated the enormous significance of the treatment decision defining it as ‘the 265 
most complex in medicine’. Many hours were required to assist patients in their decision-266 
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making and if treatment was commenced it was subsequently difficult to withdraw. 267 
Clinicians generally agreed that substantial time and thought should be devoted to the process 268 
to ensure appropriate interventions. The cost of treatment was also alluded to in light of poor 269 
prognosis and reduced quality of life.  270 
This is one of the most complex areas in medicine to make decisions on, and it’s becoming more complex because 
of the types of patients we’re now being asked to deal with… These are patients that are elderly and frail, with lots 
of comorbidities, sometimes very severe, like dementia, cancer, and these are the decisions which are becoming 
really, really difficult to make, and no consultant I know can make these decisions easily. If they do make them 
easily, they’re doing it wrong.  These decisions are extremely difficult. They have to be individualised for each 
patient. They take hours of talking.  Very rarely is this decision easy in the majority of elderly frail patients (CNS02). 
 
Once you initiate treatment, it becomes really difficult to stop it again, so we do not want to initiate treatment 
inappropriately in patients where we’re not going to benefit quality of life or their lifespan because they’re going to 
die from heart failure, dementia, cancer, whatever.  It’s one of the more difficult areas in medicine to explore. It’s 
also an extremely expensive therapy that we don’t want to use inappropriately in a very cash-strapped NHS, and so 
we have to make sure that we’re doing the right thing for the patient and use this treatment as appropriately as we 
can, otherwise, if we just willy-nilly start people on dialysis, without any thought whatsoever, that would be a 
disaster, for patients, family, but also for the NHS in general (N06).   
 
No, I don’t think the decision is easy for them to make, and it doesn’t matter what age the patient is. Everybody, at 
different stages of life, has their own personal lives, their own issues. Dialysis or no dialysis, and thinking about 
the end of life is huge and I don’t think, you know, that… we can really appreciate the impact of trying to make that 
decision, because we can give them as much information as we like, but you can’t come up with every scenario 
that this patient’s going to go through, and you can just give them a picture, a snippet (N18). 
 271 
A brave and informed decision 272 
Clinicians may have attempted to influence the decision of patients in an attempt to help them 273 
make an optimal decision but they applauded patients who made an autonomous decision for 274 
CM and talked of a ‘brave decision’. These patients had re-evaluated their lives and what 275 
they hoped to gain by living longer. This was viewed as a ‘crossroads’ in life where a patient 276 
could accept their failing health and impending death.  277 
To come to that, you would have had to re-evaluate where you are in life and what you hope to gain from living 
longer, and so, you know, it’s that crossroad where you say, right, I’m at the point when my physical and mental 
health is such that I don’t think it’s worth living that much longer and I accept what I’ve got at present and so be it 
(N13). 
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If they’re given the information in the proper way, they’re beginning to face the reality that life is fragile, very fragile, 
and I think they probably are to be very much admired, for the decisions that they make. It’s so unpredictable, renal 
failure as a whole, so unpredictable … it’s not easy (CNS20). 
 278 
The patients who opted not to dialyse and were clear in their decision-making appeared to 279 
have less decisional conflict according to clinicians. They rarely altered their decision, even 280 
though clinicians reported regularly checking that they were satisfied with their decision, as it 281 
was viewed as inevitably leading to death. 282 
“I’m old, I’ve done this and I’ve done that, and do you know what, if I die, I die.”  Do you know?  And then you know 
that they are satisfied and they say, “…  I was happy with my life,” you know, I have done this and that and I’m 
happy to go if I have to go” (CNS05). 
 
I think if properly supported, patients who make that decision [conservative management] do in fact stick to their 
decision.  We are very careful to ensure that, even towards the very end, we say to them that they can change their 
minds.  But in my experience, none have (N13). 
 283 
Benefits, risks and prognostic uncertainty 284 
Clinicians reported that patients were generally able to identify the benefits of treatment but 285 
focused less on risks and side-effects. They found difficulty helping patients identify these 286 
phenomena as their views often differed to patients. Clinicians tended to focus on the more 287 
medical and technical aspects of care but were aware that patients often adopted a more 288 
personalised perspective. 289 
It’s very difficult because healthcare professionals and patients often perceive that the other is talking about 
something else – Often, we’re interested in the conversation about the need to start dialysis based on a 
combination of symptoms and biochemical results, whereas, what we probably should be discussing [laughing] is 
what matters most to the patient. But there needs to be very transparent conversation, which often doesn’t happen, 
about time at home, time to death, which is very difficult to put your finger on, and the likelihood of hospitalisation.  
And it’s very difficult and the bottom line is I’m not sure that in all my patients understand what benefits matter 
most to them when making these decisions about electing to have or not to have dialysis (N12). 
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Clinicians also felt patient experience was individual in nature. Not having experienced the 290 
situation patients found themselves in, clinicians often felt unable to appreciate the subtle 291 
needs of each patient and their individual understanding of the situation at an empathetic 292 
level. Often this led to a more cautious and safe and clinical approach. 293 
So, probably, we’re too conservative about our conservative management [laughing] because there’s probably a lot 
more people who shouldn’t do dialysis but we kind of think, mm, give them…give them the benefit of the doubt and 
try it, saying that they can stop if they don’t like it, but, you know, once you start something, it’s harder to stop than 
never starting it in the first place (N11) 
Clinicians discussed the uncertainty of prognostic predictions and the risk of giving 294 
misleading information related to prognosis which could prove erroneous. This was made 295 
more difficult by the fact that most clinicians could cite an example of a patient who had 296 
done well on dialysis against the odds. 297 
He was unconscious, very ill and in his eighties. You’d say this man’s too sick to do anything, but we talked to his 
family and they said, no, they wanted to give him the chance at dialysis, and we did.  He lived for at least another 
three years at home with his family and was eternally grateful – every time I came in, he was “Thank you,” oh…and 
it was like, well, I just don’t know.   We don’t know what’s going to happen in any individual patient, so you cannot 
be too sort of, judgmental on what to do 
 298 
The difficulties in predicting outcomes led to conundrums where clinicians focused on 299 
positive aspects of treatment largely on the basis of predictive uncertainty regarding 300 
treatment. 301 
I think we sometimes tend to focus on the positive points of each option rather than dwelling on the negative 
aspects of the alternate option (N11). 
It’s probably something that we don’t go into a lot of detail with them because, obviously, we don’t really know the 
risks ourselves of what will happen along the way (CNS21) 
 302 
Discussion 303 
In exploring decisional conflict in patients deciding between dialysis and CM it is clear that 304 
clinicians are in an unenviable position of attempting to assist patients in making decisions 305 
where clinical outcomes are uncertain. Clinicians face uncertainty when making prognostic 306 
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predictions, as precise predictions are likely to be misleading and may prove ultimately 307 
inaccurate. Patient-centred decision-making is challenging and is hindered by confusion 308 
surrounding the balance of benefits versus risks of treatment, with patients frequently 309 
changing their minds over treatment options. In the present study, clinicians discussed their 310 
reluctance to focus on the negative aspects of treatment, such as difficult symptoms and 311 
limited prognosis in the face of uncertainty. Unfortunately, an attempt to avoid discussion of 312 
declining health and approach of death is likely to lead to patients being unlikely to fully 313 
appreciate the clinical status and severity of their condition; the fact that their health will 314 
continue to fail and that death will inevitably follow. In addition, if the difficult aspects of 315 
treatment options and symptomatology are not clearly extrapolated for patients, their 316 
decision-making may well be skewed towards dialysis rather than CM.  317 
 318 
There is a clear need for an honest and open shared decision-making approach to enable 319 
people with ESKD to decide what treatment might suit them best, although it is 320 
acknowledged that prognostic uncertainty makes this difficult. In helping patients make 321 
decisions, clinicians face conflict themselves as they decide what should be discussed and 322 
whether appropriate influence is indicated. In discussing patient decisions, clinicians have 323 
uncovered their own conflicts when deliberating treatment options. Recurring, expressed 324 
humour, in many interviews, indicated a degree of incongruity or perception of things not 325 
being as they should; also perhaps indicative of a conflicted situation for these clinicians 326 
living and working with uncertainty. 327 
In this study, clinicians faced similar dilemmas to those previously highlighted 23,24,25,48  often 328 
preferring to avoid difficult end of life discussions for fear of reducing hope. Discussion 329 
about CM may be constrained by a combination of poor timing of information and reluctance 330 
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of clinicians to be more explicit about quality of life and survival with dialysis. That said, it is 331 
highly likely that patients and clinicians both differ in their experiences of decision-making. 332 
Shared treatment decision-making is a term that remains elusive21. Many practitioners believe 333 
the concept of shared decision-making is clear and that a definition is not required, leading to 334 
varied interpretations by patients and clinicians with resultant ambiguity and 335 
misunderstanding49 50 51.Outside of the nephology discipline, shared decision-making has a 336 
stronger evidence base, particularly in cancer, and decision aids are frequently used in these 337 
arenas27,50. A recent Cochrane review of decision aids  to help people  facing treatment or 338 
screening decisions27 found high quality evidence that decision aids, compared to usual care, 339 
improve knowledge of options, improve communication, encourage active involvement in 340 
decision-making and improve risk perceptions and congruence between the choice made and 341 
patient values. The Dialysis Decision-aid Booklet, ‘Dialysis: making the right choices for 342 
you52 should prove to be a useful tool but requires a CM component for deployment within 343 
this patient group. The use of decision aids has demonstrated a poor uptake within 344 
nephrological circles and there are few studies of interventions in the current literature. 345 
Limitations 346 
This study makes tentative claims of generalisability because although it relies on interpretive 347 
description rather a constructed truth38, it is likely that many of the findings will resonate with 348 
practitioners globally. It encompassed views garnered from practitioners from across ten 349 
renal units in the UK so some similarities in experience may be drawn. The results may be 350 
influenced by the first author’s personal biases, but a second author (SH) assisted with the 351 
data analysis, and interviews were shared and analysed by all authors. The study did not 352 
include interviews with patients.  353 
Conclusion 354 
Clinicians report decisional conflict, and uncertainty, in patients making decisions between 355 
dialysis and CM, and feel conflicted themselves. They endeavour to act as a clinical advocate 356 
acting in the patients best interests, offering guidance based on the treatment they believe 357 
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might suit the patients,  whilst at times withholding information. A more patient-centred 358 
approach to decision-making is required27 53  with additional education and training although 359 
equipoise is acknowledged . Interventions aimed at increasing comprehension of this disease 360 
and its’ treatments may reduce decisional conflict and augment decisional quality, but such 361 
interventions have been rarely tested within the territory of renal medicine. 362 
(3330) 363 
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